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Abstract  Arrhythmogenic  right  ventricular  dysplasia/cardiomyopathy  (ARVD/C)  is  an  inher-
ited heart  muscle  disease  that  predominantly  affects  the  right  ventricle.  Clinical  manifestations
are related  to  severe  ventricular  arrhythmia  that  may  lead  to  sudden  death,  mostly  in  young
patients.  Magnetic  resonance  imaging  (MRI),  included  in  the  new  diagnostic  criteria  since  2010,
aims to  detect  segmental  and  global  wall  motion  abnormalities,  reduced  ejection  fraction,  right
ventricular  dilatation  and  right  ventricular  diastolic/systolic  dysfunction.  An  MRI  assessment  of
the right  ventricle  is  often  challenging,  partly  because  the  MRI  diagnostic  criteria  have  some
limitations,  and  also  because  it  requires  a  signiﬁcant  learning  curve  due  to  the  low  prevalence
of the  disease.  Therefore,  this  article  aims  to  review  the  pathophysiology  of  the  disease,  the
cardiac MRI  protocol,  images  of  the  various  stages  of  this  affection  as  well  as  the  differential
diagnosis.© 2015  Éditions  franc¸aises  de  radiologie.  Published  by  Elsevier  Masson  SAS.  All  rights  reserved.Arrhythmogenic  right  ventricular  dysplasia  (ARVD)  or  arrhythmogenic  right  ventricular
cardiomyopathy  is  an  inherited  cardiomyopathy  characterized  by  ﬁbro-fatty  replace-
ment,  mainly  affecting  the  right  ventricle  (RV)  but  also  the  left  ventricle  (LV).  In  50%
of  the  cases,  this  genetic  disease  is  inherited  in  an  autosomal  dominant  pattern  with
mutations  in  the  genes  coding  for  desmosomal  proteins.  ARVD  causes  severe  ventricular
Abbreviations: ARVD, Arrhythmogenic right ventricular dysplasia; MRI, Magnetic Resonance Imaging; RV, Right ventricle; LV, Left ventricle;
ECG, Electrocardiogram.
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rrhythmias  in  young  individuals  and  is  responsible  for  sud-
en  death.  There  is  no  pathognomonic  feature  of  ARVD,  thus
iagnosis  is  based  on  a  combination  of  clinical,  electrical  and
orphological  criteria,  as  reported  in  the  literature  [1].
Franck  and  Fontaine  ﬁrst  described  the  disease  in  1978.
nitial  diagnostic  criteria  followed  in  1994.  Recent  genetic
ndings  as  well  as  advances  in  cardiac  imaging,  especially
n  MRI,  have  led  experts  to  update  the  criteria  in  2010,  by
dding  cardiac  MRI  to  the  imaging  modalities  [1].
MRI  assessment  of  the  disease  is  challenging  for  the  fol-
owing  reasons:
the  right  ventricle  is  functionally  totally  different  from
the  left  ventricle;
a  high  number  of  artifacts  on  cine  sequences  (SSFP)  due
to  the  anterior  position  of  the  RV  against  the  chest  wall,
thereby  compromising  the  quality  of  the  ﬁndings  that  may
be  misinterpreted  for  dyskinesia;
RV  volume  and  ejection  fraction  are  difﬁcult  to  measure
and  very  dependent  on  the  loading  conditions;
frequent  artifacts  related  to  the  detection  of  associated
signs  such  as  fat  inﬁltration  and  retention  of  contrast  in
the  myocardial  wall.
This  article  reviews:
what  radiologists  must  know  about  ARVD;
how  to  perform  an  MRI  assessment;
how  to  measure  the  ejection  fraction  of  the  RV  using  com-
mercially  available  equipment;
what  signs  to  look  for  to  diagnose  ARVD;
what  are  the  other  disorders  causing  similar  signs,  and
differential  diagnosis.
linical and pathophysiological
haracteristics
RVD  is  a  genetic  cardiomyopathy.  The  inheritance  pattern
s  usually  autosomal  dominant  with  variable  penetrance  and
xpression,  and,  but  far  less  often,  autosomal  recessive.  The
ncidence  of  the  familial  form  of  ARVD  is  estimated  between
5  and  50%  [2].  The  majority  of  the  mutations  are  in  genes
oding  for  desmosomal  proteins  (desmoplakin,  plakoglobin,
lakophilin-2,  desmoglein-2,  and  desmocollin-2)  involved  in
he  intercellular  connection  between  myocytes.  Desmoso-
al  dysfunction  is  believed  to  cause  myocytes  to  detach
rom  each  other,  leading  to  cell  death,  inﬂammation  and
epair  by  ﬁbro-fatty  substitution,  and  ﬁnally  RV  dysfunction
nd  dilatation  [3].
The  prevalence  of  ARVD  is  estimated  between  1:2000
nd  1:5000.  There  is  a  male  predilection,  with  a  male-to-
emale  ratio  3-1  [2].  ARVD  is  a  major  cause  of  sudden  death
n  athletes.  The  ﬁrst  symptoms  generally  occur  between
he  second  and  ﬁfth  decades  of  life  (median  age:  29  years).
he  presenting  symptoms  include  palpitations,  syncope  and
udden  death  in  decreasing  order  of  frequency.  The  inci-
ence  of  sudden  death  decreases  after  the  fourth  decade
2],  but  incidence  of  heart  failure  in  ARVD  patients  has  been
eported  to  follow  in  20%  of  the  cases.  Annual  mortality  rate
s  2.3%  and  the  mean  age  at  death  is  54  ±  19  years.  The  pri-
ary  causes  of  death  are  heart  failure  and  sudden  death.
 diagnosis  of  ARVD  makes  family  screening  necessary  to
(
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etect  subclinical  manifestations  of  the  disease;  and  genetic
esting  may  be  considered  [3].
iagnostic criteria
RVD  is  difﬁcult  to  diagnose.  It  is  based  on  clinical  and
araclinical  criteria,  including  family  history.  The  diagnos-
ic  criteria  were  revised  in  2010  and  are  subdivided  into
ajor  and  minor  criteria  (Table  1).  A  ‘‘deﬁnite’’  diagno-
is  consists  of  2  major  criteria  or  1  major  and  2  minor
riteria,  or  else  4  minor  criteria.  A  ‘‘borderline’’  diagnosis
onsists  of  1  major  and  1  minor  criterion  or  3 minor  criteria.
inally  a  ‘‘possible’’  diagnosis  consists  of  1  major  or  2  minor
riteria.  The  criteria  were  updated  by  including  RV  func-
ional  abnormalities  detectable  by  echocardiograms,  MRI
nd  angiography,  histological  evidence  from  endomyocar-
ial  biopsy  specimens,  electrocardiographic  abnormalities
repolarization,  conductivity,  and  arrhythmia),  and  informa-
ion  from  family  history  [1].
Thus,  MRI  must  be  part  of  a  comprehensive  evaluation  of
he  disease  and  be  based  on  speciﬁc  clinical,  electrocardio-
raphic  and  arrhythmic  criteria,  as  deﬁned  by  the  Marcus
iagnostic  criteria.
Other  morphological  abnormalities  such  as  fat  inﬁltra-
ion  and  delayed  enhancement  images,  are  detectable  by
RI,  but  have  not  been  included  in  the  diagnostic  criteria.
hese  abnormalities  are  described  here  and  their  detection
s  useful  in  case  of  wall  motion  abnormalities.
RI
RI  is  performed  while  the  patient  is  in  supine  position,
ith  an  imaging  system  that  comprises  a  dedicated  car-
iac  coil  and  ECG  monitoring.  ECG-synchronized  cardiac  MRI
mages  are  acquired  during  breath-holding  in  the  following
lanes:  4-chamber,  short  axis,  RV  and  LV  2-chamber  views
nd  infundibular  view  (Fig.  1).  Fig.  1  shows  the  axes  for  the
nalysis  of  the  RV;  the  LV  axes  are  widely  described  in  the
iterature.
In  some  patients,  MRI  assessment  may  be  hindered  or
revented  by  artifacts  caused  by  extrasystoles.  There  are
wo  ways  to  overcome  this.  The  ﬁrst  way  is  to  adminis-
er  a  beta-blocking  antiarrhythmic  drug  (5  mg  Atenolol  by
low  intravenous  injection).  For  a  patient  with  extrasys-
oles  despite  a  long-term  beta-blocking  treatment,  we  use
tropine  (1  mg  diluted  into  10  mL  saline  serum  injected  over
 period  of  2  min)  to  increase  cardiac  rate,  and  restore  a
egular  heart  rate.  Such  a treatment  may  not  be  initiated  in
ase  of  polymorphic  extrasystoles.  Another  possibility  is  to
se  SSFP  sequences  with  arrhythmia  rejection.
rotocol
ine imagingFIESTA,  true-FISP,  Balanced  Fast  Field  Echo):  T2/T1
eighted  sequences,  where  ﬂuids  appear  bright  (« bright
lood  hypersignal». They  are  less  sensitive  to  ﬂow-related
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Table  1  Arrhythmogenic  right  ventricular  dysplasia  (ARVD)  diagnostic  criteria  according  to  the  2010  Revised  Task  Force
Criteria.
Major  criteria  Minor  criteria
Structural  dysfunctions
and abnormalities
Echocardiography  Regional  RV  akinesia,  dyskinesia  or  aneurysm
And  one  of  the  following
Pulmonary  infundibulum  ≥  32  mm  in
parasternal  long  axis  (≥  19  mm/m2)
Pulmonary  infundibulum  ≥  36  mm
(≥  21  mm/m2)
Or  fractional  infundibulum  area  change  ≤  33%
Regional  RV  akinesia,  dyskinesia  or  aneurysm
And  one  of  the  following
Pulmonary  infundibulum  ≥  29  mm  —  <  32  mm  in
parasternal  long  axis  (≥  16  mm  —  <  19  mm/m2)
Pulmonary  infundibulum  ≥  32mm  —  <  36  mm
(≥  18mm  —  <  21  mm/m2)
Or  fractional  infundibulum  area
change  >  33%  —  ≤  40%
MRI  Regional  RV  akinesia  or  dyskinesia  or
dyssynchronous  RV  contraction
And  one  of  the  following
RV  end-diastolic  volume  index  ≥  110  mL/m2
(male)  or  ≥  100  mL/m2 (female)
Or  RV  ejection  fraction  ≤  40%
Regional  akinesia  or  dyskinesia  or
dyssynchronous  RV  contraction
And  one  of  the  following
100  ≤  RV  end-diastolic  volume
(EDV)  <  110  mL/m2 (male)  or
90  ≤  EDV  <  100  mL/m2 (female)
Or  40%  <  RV  ejection  fraction  ≤  45%
Angiography  Segmental  akinesia  or  dyskinesia  or  aneurysm
Tissue
characterization,
histology
Residual  myocytes  <  60%  by  morphometric
analysis  (or  <  50%  if  estimated),  with  ﬁbrous
replacement  of  the  RV  free  wall  myocardium
in  ≥  1  sample,  with  or  without  fatty
replacement  on  endomyocardial  biopsy
Residual  myocytes  60%  —  75%  by  morphometric
analysis  (or  50%  to  65%  if  estimated),  with
ﬁbrous  replacement  of  the  RV  free  wall
myocardium  in  ≥  1  sample,  with  or  without
fatty  replacement  on  endomyocardial  biopsy
Repolarization
abnormalities
Inverted  T  waves  in  right  precordial  leads
(V1,  V2  and  V3)  or  beyond  in
individuals  >  14  years  of  age  (in  the  absence
of  complete  right  bundle-branch  block  with
QRS  ≥  120  ms)
Inverted  T  waves  in  leads  V1  and  V2  in
individuals  > 14  years  of  age  (in  the  absence  of
complete  right  bundle-branch  block)  or  in  V4,
V5  or  V6
Inverted  T  waves  in  leads  V1,  V2,  V3  and  V4  in
individuals  > 14  years  of  age  in  the  presence  of
complete  right  bundle-branch  block
Depolarization  and
conduction
abnormalities
Epsilon  waves  (low-amplitude  signal  between
end  of  QRS  and  onset  of  the  T  wave)  in  the
right  precordial  leads  (V1  to  V3)
Late  potentials  in  ≥  1  of  3  parameters  in  the
absence  of  a  QRS  duration  of  ≥  110  ms
Filtered  QRS  duration  (fQRS)  ≥  114  ms
Duration  of  terminal  QRS
(amplitude  <  40  V)  ≥  38  ms
Root-mean-square  voltage  of  terminal
40  ms  ≤  20  V
Terminal  activation  duration  of  QRS  ≥  55  ms
measured  from  the  nadir  of  the  S  wave  to  the
end  of  the  QRS,  including  R’  in  V1,  V2  or  V3,  in
absence  of  complete  right  bundle-branch  block
Arrhythmias  Sustained  or  nonsustained  ventricular
tachycardia  with  left  bundle-branch
morphology  with  superior  axis  (negative  or
indeterminate  QRS  in  leads  DII,  DIII  and  VF
and  positive  in  lead  VL)
Sustained  or  nonsustained  left  bundle  branch
block-type  ventricular  tachycardia  with
inferior  axis  (positive  QRS  in  leads  DII,  DIII  and
VF  and  negative  in  lead  VL)  or  of  unknown  axis
>  500  ventricular  extrasystoles  per  24  h  (Holter)
Family  history  ARVD  conﬁrmed  in  a  ﬁrst-degree  relative  who
meets  Task  Force  criteria
ARVD  conﬁrmed  pathologically  at  autopsy  or
surgery  in  a  ﬁrst-degree  relative
Identiﬁcation  of  pathogenic  mutation
categorized  as  associated  or  probably
associated  with  ARVD  in  the  patient  under
evaluation
History  of  ARVD  in  ﬁrst-degree  relative  in
whom  it  is  not  possible  or  practical  to
determine  whether  the  family  member  meets
current  Task  force  criteria
Premature  sudden  death  (<  35  years  of  age)  due
to  suspected  ARVD  in  a  ﬁrst-degree  relative
ARVD  conﬁrmed  pathologically  or  by  Task  Force
criteria  in  a second-degree  relative
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Figure 1. The short-axis plane (C) is used to measure the volume
and ejection fraction of the left ventricle (LV) and right ventricle
(RV); it is placed perpendicular to the 4-chamber (red axis A) and 2-
chamber (red axis B) views. The ‘‘RV long-axis’’ plane (F) is planned
from the 4-chamber (D) and the basal short-axis (E) planes, at ﬁrst it
is oriented along the interventricular septum, then double rotation
about 10 degrees 1) from the anterior section towards the apex of
the heart (red axis D), and 2) from the base to the pulmonary artery
in oblique sagittal plane (red axis E), through the apex of the RV and
the root of the pulmonary artery. The last plane of the assessment
goes through the infundibulum (H); this plane is obtained from the
RV 2 — chamber plane, by placing the plane through the main pul-
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Intramyocardial  fat  inﬁltration  and  delayed  enhance-onary artery perpendicular to the RV 2 — chamber plane (red axis
).
rtifacts.  These  sequences  provide  good  contrast  between
lood  pool  and  myocardium  showing  clear  delineation
f  endocardial  borders.  Therefore,  they  are  used  for
he  assessment  of  the  segmental  and  global  ventricular
ysfunction  (ejection  fraction  and  volume  measurement)
s  well  as  for  the  anatomic  assessment  of  the  cardiac
hambers  [4].  These  imaging  sequences  are  essential  to
etect  RV  dysplasia,  since  they  are  able  to  evidence  the
iagnostic  criteria.  Therefore,  we  use  them  as  ﬁrst-line
maging  modality.
The  views  are  four-chamber,  short  axis,  LV  and  RV
ong  axis  and  RV  infundibulum.  In  our  group,  we  use
he  4-chamber  view  to  visualize  the  entire  right  ventri-
le  (5  slices).  Slice  thickness  is  6  mm,  with  repetition  time
TR)  ≤  35  ms,  minimum  time  to  echo  (TE),  and  36  to  40  cm
eld  of  view  (FOV)  [5].
orphologic sequences
lack-blood  T1  Spin  Echo  or  Turbo  Spin  Echo  to  prevent
rtifacts  from  intracavitary  ﬂow.  Fat  saturation  or  double
nversion  recovery  pulses  may  be  added  to  suppress  fat  sig-
al.
Sequences  are  acquired  during  breath-holding  in  the  4-
hamber  and  short-axis  views.  The  latter  allows  us  to  clearly
ssess  the  RV  free  wall  and  the  infundibulum.  Imaging  starts
rom  the  diaphragm  to  the  pulmonary  artery.
m
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Black  blood  single  shot  fast  spin  echo  sequences  reduce
otion  artifacts  and  shorten  the  imaging  time,  but  at  the
ost  of  loss  of  visualization  of  the  RV  wall  [4].
These  sequences  are  useful  to  identify  intramyocardial
at  inﬁltration.
elayed contrast enhancement sequence
inversion recovery gradient echo)
his  sequence  is  acquired  10  to  15  min  after  IV  injection
f  gadolinium  chelates  (0.2  mL/kg).  Images  can  be  acquired
sing  2D  or  3D  techniques,  but  require  speciﬁc  adjustment
f  the  inversion  time  of  the  right  ventricle.
Sequences  are  performed  in  the  4-chamber  and  short-axis
iews.
Phase-sensitive  Inversion-Recovery  sequences  generate
mages  that  are  not  sensitive  to  inversion  time  artifacts  [4].
ptimal protocol selection
SFP  cine  sequences  are  the  most  important  ones  to  evi-
ence  signs  of  ARVD.  In  our  group,  we  perform  the  complete
et  of  cine  imaging.  Only  in  case  of  abnormal  cine  sequences,
o  we  acquire  T1  and  delayed  enhancement  images.
V ejection fraction
RI  is  currently  considered  the  Gold  Standard  for  mea-
uring  ventricular  function;  its  excellent  spatial  resolution
as  proven  to  be  a  speciﬁc  and  reproducible  tool  to  eval-
ate  LV  and  RV  anatomy,  volume  and  myocardial  mass.
his  is  particularly  true  for  the  RV  since  data  provided  by
chocardiographic  and  isotopic  techniques  may  be  difﬁcult
o  interpret  especially  when  the  RV  has  an  abnormal  shape
r  size.
Simpson’s  rule  method  is  used  (just  like  for  the  LV)  [6].
nfundibulum  must  be  included  in  the  measurement  because
t  can  account  for  25  to  30%  of  RV  volume.  Two  rules  to
ccurately  contour  and  measure  the  RV  are:
to  determine  the  most  basal  level  of  the  RV  and  to  sep-
arate  it  from  the  right  atrium  in  the  short-axis  images.
Short-  and  long-axis  cine  sequences  are  helpful  for  this;
to  perform  an  endocardial  contouring  with  inclusion  of  the
RV  trabeculae  in  the  ventricular  cavity  at  end-diastole  and
systole  (Fig.  2).
RI ﬁndings
all motion and functional abnormalities
nlike  the  initial  diagnostic  criteria,  the  2010  updated  crite-
ia  are  quantitative.
Only  three  types  of  MRI-detectable  abnormalities  have
een  included  in  the  criteria  to  diagnose  ARVD:  segmental
V  wall  motion  abnormalities,  RV  dilatation  and  reduction
f  ejection  fraction.ent  have  not  been  included.
A  major  criterion  detectable  by  MRI  is  the  combination
f  regional  RV  akinesia  or  dyskinesia  or  dyssynchronous  RV
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Figure 2. Technique to measure the ejection fraction of the right ventricle (RV): the systole (Sys.) and diastole (Dia.) frames are selected.
The most basal slice of the RV is different in systole and diastole. It is important to include the infundibulum in the measurement; the
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contraction  with  one  of  the  following:  ratio  of  RV  end-
diastolic  volume  to  body  surface  area  ≥  110  mL/m2 in  male
patients  and  ≥  100  mL/m2 in  female  patients  or  RV  ejection
fraction  ≤  40%.
A  minor  criterion  is  the  combination  of  regional  RV
akinesia  or  dyskinesia  or  dyssynchronous  RV  contraction
with  one  of  the  following:  100  ≤  RV  volume  at  end-
diastole  <  110  mL/m2 in  male  patients  and  90  ≤  Volume  at
end-diastole  <  100  mL/m2 in  female  patients  or  40%  <  RV
ejection  fraction  ≤  45%  [1].
Reduction of the ejection fraction
Segmental  wall  motion  abnormalities  and  RV  dilatation  mod-
ify  the  RV  ejection  fraction.
When  associated  with  segmental  wall  motion  abnormal-
ities,  an  RV  ejection  fraction  ≤  40%  is  considered  a  major
criterion,  and  a  minor  criterion  if  between  41  and  45%.
Right ventricle dilatation
The  evolution  of  the  RV  volume  is  key  in  monitoring  the
progression  of  the  disease  [7].  RV  dilatation  may  be  seg-
mental,  typically  involving  the  infundibulum,  or  the  basal
or  else  mid-ventricular  segment  of  the  free  wall,  or  may
•
•he short-axis plane, by the atrioventricular groove (arrow).
e  global  (Fig.  3).  The  diagnostic  sensitivity  and  speciﬁcity
f  ventricular  dilatation  for  ARVD  is  77%  and  95—100%,
espectively  [7].
all motion abnormalities
he  detection  of  focal  contraction  abnormalities  is  more
ubjective  than  the  measurement  of  RV  volume  and  ejec-
ion  fraction.  MRI  interpretation  of  the  right  ventricle  and
he  RV  free  wall  in  the  strict  axial  view  can  produce  many
rtifacts,  due  to  magnetic  ﬁeld  inhomogenities,  causing
alse-positive  readings  of  dyskinesia.  The  artifacts  are  less
isible  on  the  4-chamber  sequences  but  local  shimming  is
ometimes  required  to  avoid  them  (Fig.  4).  We  highly  rec-
mmend  the  use  of  4-chamber  views  for  the  assessment  of
V  wall  motion  abnormalities  [8].
The  wall  motion  abnormalities  to  evaluate  are  [7]:
hypokinesia  where  an  area  or  segment  of  the  ventricular
wall  is  characterized  by  reduced  systolic  wall  thickening
or  shortening  (wall  thickening  <  40%)  (Fig.  5; Cine  1);
akinesia:  systolic  wall  thickening  <  10%  (Fig.  6;  Cine  2);
dyskinesia:  abnormal  outward  movement  during  systole
(Fig.  7;  Cine  3);
454  A.  Tavano  et  al.
Figure 3. 57-year-old man with diagnosed arrhythmogenic right ventricular dysplasia (ARVD). Right ventricle (RV) global hypokinesia
with marked dilatation of the RV and secondary right atrial dilatation. The left ventricle (LV) volume is normal without any wall motion
abnormality: a: SSFP multi shot sequence, 4-chamber view, at end-diastole; b; SSFP multi shot sequence, 4-chamber view, at end-systole;
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(: SSFP multi shot sequence, short-axis view at end-diastole; d: SSF
equence, RV long-axis view, at end-diastole; f: SSFP multi shot seq
diastolic  bulging  or  bulging:  dyskinetic  area  during  systole
with  aneurysm  during  diastole  (Fig.  8; Cine  4  and  5).
These  functional  abnormalities  often  correlate  with  areas
f  signal  abnormality  visible  on  black  blood  sequences.
bnormal  wall  motion  associated  with  black  blood  signal
bnormality  are  more  suggestive  of  ARVD  than  either  abnor-
ality  alone  [7].  These  segmental  wall  motion  abnormalities
o
a
igure 4. a: 4-chamber view showing an artifact at the apex of the rig
rrows); b: we note the absence of the artifact on the sequence in the 
open arrow).ti shot sequence, short-axis view at end-systole; e: SSFP multi shot
e, RV long-axis view, at end-systole.
sually  affect  the  basal  and  mid  ventricular  segments  of  the
V  free  wall  with  an  incidence  of  70—80%.  Speciﬁcity  reaches
00%  if  these  dyskinetic  areas  show  segmental  dilatation  of
he  RV.On  the  other  hand,  false-positive  signals  of  bulging  at  end
f  diastole  in  individuals  free  of  ARVD  are  possible.  These
rtifacts  are  seen  at  the  apical  third  of  the  RV  free  wall.
ht ventricle (RV) (broad arrow), in front of the RV wall (small white
same 4-chamber view, but with a slightly different radiofrequency
MR  imaging  of  arrhythmogenic  right  ventricular  dysplasia  455
Figure 5. 46-year-old man resuscitated from ‘‘sudden death’’ without any history of cardiomyopathy. Functional analysis shows global
 sequ
c
e
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t
thypokinesia of the right ventricle (RV) free wall; a: SSFP multi shot
4-chamber view at end-systole.
Morphological abnormalities
Intramyocardial fat inﬁltration
Intramyocardial  fat  has  long  been  considered  a  major  MRI
diagnostic  criterion,  however  today  it  is  considered  less  reli-
able.
Epicardial  fat  inﬁltrates  from  the  epicardium  to  the  endo-
cardium  of  the  myocardial  wall,  causing  a  disruption  in  the
t
i
s
Figure 6. 10-year-old child with suspected arrhythmogenic right ven
motion abnormalities: akinesia of basal free wall segment (full arrow), ar
of the RV apex (dotted arrow); a: SSFP multi shot sequence, short-axis v
at end-systole; c: SSFP multi shot sequence, 4-chamber view at end-diasence 4-chamber view at end-diastole; b: SSFP multi shot sequence
lear  line  of  demarcation  between  the  myocardium  and  the
picardial  fat  (Figs.  9  and  10).  Fat  usually  appears  as  an
ntramyocardial  hyperintense  spin-echo  T1  signal.  Fat  inﬁl-
rates  into  the  following  areas:  infundibulum,  RV  free  wall,
rabeculae,  RV  moderator  band  and  right  side  of  the  ven-
ricular  septum.
The  prevalence  of  intramyocardial  hyperintense  signals
n  ARVD  patients  ranges  between  22  to  75%  in  different
tudies.
tricular dysplasia (ARVD). Imaging shows several segmental wall
ea of dyskinesia on the mid-free wall (arrowhead) and hypokinesia
iew, at end-diastole; b: SSFP multi shot sequence, short-axis view,
tole; d: SSFP multi shot sequence, 4-chamber view at end-systole.
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Figure 7. 43-year-old man with suspected arrhythmogenic right ventricular dysplasia (ARVD) following syncope. Wall motion analysis
s ntric
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ehows two dyskinetic areas, one at the inferior wall of the right ve
: SSFP multi shot sequence, RV long-axis view, at end-diastole; b: 
Moreover,  there  is  poor  inter-observer  reproducibility  for
he  analysis  and  MRI  detection  of  fat  due  to:
the  presence  of  epicardial  and  pericardial  fat,  which
makes  identiﬁcation  of  intramyocardial  fat  challenging;
the  subtricuspid  area  may  be  difﬁcult  to  distinguish  from
the  atrioventricular  groove,  which  is  rich  in  fat;
the  RV  free  wall  is  only  3—5  mm;  the  spatial  resolution  of
cardiac  MRI  is  therefore  often  not  so  good;
r
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igure 8. 59-year-old man with suspected arrhythmogenic right ventr
RV) segmental wall motion abnormalities in one patient with dilated RV: 
all (dotted arrow) and of the apex (full white arrow), dyskinesia at the i
iew at end-diastole; b: SSFP multi shot sequence, 4-chamber view at en
nd-diastole; d: SSFP multi shot sequence in the infundibular plane at ele (RV), the second one at the level of the infundibulum (arrows);
 multi shot sequence, RV long-axis view, at end-systole.
the  normal  presence  of  fat  deposits  in  healthy  individuals.
These  deposits  are  observed  in  healthy  individuals  in  15%
f  the  cases,  most  often  in  the  anteroapical  region  of  the
ight  ventricle  and  in  up  to  50%  in  overweight  individuals.
he  prevalence  is  also  higher  in  older  people.
Some  experts  recommend  correlating  these  intramy-
cardial  hyperintense  signals  with  segmental  wall  motion
icular dysplasia (ARVD) following syncope. Multiple right ventricle
akinesia of the basal free wall (black arrow), bulging at the mid  free
nfundibulum (arrowhead); a: SSFP multi shot sequence, 4-chamber
d-systole; c: SSFP multi shot sequence in the infundibular plane at
nd-systole.
MR  imaging  of  arrhythmogenic  right  ventricular  dysplasia  
Figure 9. (same patient as in Fig. 7). Subepicardial fat inﬁltration
of the right ventricle (RV) free wall (black arrows). TSE T1 ‘‘Black-
blood’’ sequence with 4-chamber view.
Figure 10. 51-year-old woman with suspected arrhythmogenic
right ventricular dysplasia (ARVD). Transmural fat inﬁltration of
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by  electrical  stimulation.  Furthermore,  there  is  a  strongright ventricle (RV) free wall (black arrows). TSE T1 ‘‘Black-blood’’
sequence with 4-chamber view.
abnormalities  to  separate  normal  fat  from  pathological  fat
inﬁltration.
Because  of  these  difﬁculties,  intramyocardial  fat  identi-
ﬁcation  by  MRI  was  not  included  in  the  diagnostic  criteria
a
a
[
Figure 11. 48-year-old woman with suspected arrhythmogenic right ve
wall have hypertrabeculated appearance (arrows); a: SSFP multi shot se
sequence, 4-chamber view at end-systole.457
f  2010  [1].  Fat  inﬁltration  is  an  additional  argument  that
ay  conﬁrm  diagnosis  when  associated  with  dilated  ventri-
le  or  with  contractile  dysfunction.  Since  fat  inﬁltration  is
ot  considered  a  diagnostic  criterion  for  ARVD,  it  must  not
e  systematically  looked  for  in  the  absence  of  RV  functional,
olume  or  contractility  abnormality.
all thickness
everal  authors  have  reported  cases  of  ARVD  associated  with
 thinning,  or  even  a  thickening,  of  the  RV  wall  [7]. However,
he  prevalence  varies  a  lot  depending  on  the  study.  These
bnormalities  are  never  isolated  but  always  appear  in  com-
ination  with  segmental  wall  motion  abnormalities.  These
igns  have  not  been  included  in  the  international  recom-
endations  [1].
ypertrabeculation
he  incidence  of  hypertrabeculation  has  been  reported  40%
n  several  studies,  with  hypertrophied  structures,  such  as
apillary  muscles  and  moderator  band  (Fig.  11).  This  ﬁnding
as  been  equated  to  an  initial  angiographic  ﬁnding  that  had
 ‘‘stack  of  plates’’  appearance.  However,  this  abnormality
s  not  speciﬁc  for  ARVD  and  may  be  present  in  any  condi-
ion  that  results  in  RV  hypertrophy  or  dilatation,  and  should
herefore  not  be  retained  as  a  criterion.
elayed enhancement
yocardial  delayed  enhancement  images  correspond  to
reas  of  ﬁbrosis,  inﬂammation  or  edema,  where  the  extra-
ellular  volume  is  increased.  In  delayed  enhancement
mages,  retention  of  gadolinium  remains  visible  in  the  patho-
ogical  areas,  while  it  is  washed  out  of  normal  myocardium
Figs.  12—14;  Cine  6  and  7).
The  use  of  delayed  enhancement  in  ARVD  has  been
ssessed  and  was  shown  to  have  excellent  correlation  with
istological  ﬁndings  and  inducible  ventricular  arrhythmiasssociation  between  the  extent  of  delayed  enhancement
nd  RV  dysfunction.  The  prevalence  is  estimated  to  be  67%
9].
ntricular dysplasia (ARVD). Right ventricle (RV) apex and mid free
quence, with 4-chamber view at end-diastole; b: SSFP multi shot
458  A.  Tavano  et  al.
Figure 12. Cardiac magnetic resonnance imaging (MRI) in asymptomatic 54-year-old man with family history of arrhythmogenic right
ventricular dysplasia (ARVD). The different sequences show delayed enhancement in the basal free wall (arrow head) and the apex (full
arrow) with hypokinetic areas, as well as delayed contrast enhancement in the mid free wall (dotted arrow) with a dyskinetic area with
fat inﬁltration; a: SSFP multi shot sequence, 4-chamber view at and-diastole; b: SSFP multi shot sequence, 4-chamber view at end-systole;
c: TSE T1 ‘‘Black-blood’’ sequence 4-chamber view; d: delayed enhancement 4-chamber view; e: delayed enhancement 4-chamber view,
slightly different slice level; f: delayed enhancement short axis.
Figure 13. 30-year-old man with suspected arrhythmogenic right ventricular dysplasia (ARVD) based on wall motion and conductivity
abnormalities. Subepicardial delayed contrast enhancement in the right ventricle (RV) free wall with hypokinetic (full arrow) and normoki-
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Retic (dotted arrow) areas; a: SSFP multi shot sequence, short-a
nd-systole; c: delayed enhancement short axis.
However,  delayed  enhancement  has  not  been  incorpo-
ated  in  the  diagnostic  criteria  when  they  were  revised  in
010,  because  of  the  difﬁculties  to  assess  the  RV  and  its  thin
all  [1].
Delayed  enhancement  remains  however  helpful  to  con-
rm  diagnosis  when  the  ﬁbrotic  area  is  located  in  an  area
nvolved  by  contractile  abnormality.  It  will  thus  be  useful  to
ook  for,  if  the  sequences  used  for  the  functional  analysis
uggest  ARVD.
eft ventricular involvementeft  ventricular  involvement  in  ARVD  has  been  observed  for
any  years,  ever  since  the  ﬁrst  descriptions  of  the  disease.
revalence  has  been  reported  between  16  and  76%  of  the
atients,  depending  on  the  study.  Fibro-fatty  replacement
M
s
tew, at end-diastole; b: SSFP multi shot sequence, short axis, at
an  affect  either  diffusely  or  regionally;  affect  the  sep-
um  and/or,  more  often,  the  free  wall,  with  a  predilection
or  postero-septal  and  postero-lateral  areas.  Involvement  is
ubepicardial,  midwall,  or  transmural  and  extends  from  the
picardium  towards  the  endocardium.  MRI-detected  mor-
hological  abnormalities  are  identical  to  those  observed  in
he  RV  and  delayed  enhancement  may  be  observed  unre-
ated  to  the  wall  motion  abnormalities  [10]  (Fig.  15).
The  prevalence  of  LV  dysfunction  is  higher  in  patients
ith  deﬁnite  ARVD  diagnosis  than  in  patients  with  doubtful
RVD.  The  segmental  wall  motion  abnormalities,  like  for  the
V,  appear  before  the  modiﬁcation  of  the  ejection  fraction.
RI  ‘‘tagging’’  may  increase  the  sensitivity  of  the  diagnosis.
LV  involvement  has,  traditionally  been  considered  a  late
tage  manifestation  of  the  progressive  disease,  however,
his  has  recently  been  brought  into  question  with  cases
MR  imaging  of  arrhythmogenic  right  ventricular  dysplasia  
Figure 14. (Same patient than in Fig. 13). Delayed enhance-
ment of hypokinetic areas at level of infundibulum (dotted arrow)
and right ventricle (RV) free wall (full arrow) and normokinetic
area corresponding to the RV apex (arrowhead); a: SSFP multi shot
sequence, RV long-axis view, at end-diastole; b: SSFP multi shot
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Msequence, RV long-axis view, at end-systole; c: delayed enhance-
ment 4-chamber view; d: delayed enhancement RV long-axis view.
evidencing  LV  involvement  without  RV  involvement,  sup-
porting  the  adoption  of  a  new  term,  ‘‘arrhythmogenic
cardiomyopathy’’  [10].
Differential diagnosis
Right ventricular outﬂow tract tachycardiaVentricular  extrasystoles  originating  in  the  infundibulum,
due  to  abnormal  automaticity  with  triggered  activity
and  without  underlying  heart  disease,  are  considered
benign.  The  condition  may  consist  of  bursts  of  infundibular
C
T
v
s
Figure 15. 40-year-old woman with suspected arrhythmogenic right ve
family history of ARVD. Left ventricle (LV) involvement is evidenced by 
inferior and lateral walls (arrow); a: delayed enhancement short-axis vie459
entricular  tachycardia  (or  ‘‘Gallavardin  infundibular  ven-
ricular  tachycardia’’).  The  initial  examination  consists
f  Holter  monitoring,  electrocardiogram,  echocardiogra-
hy  and  sometimes  a  stress  test  and/or  in  some  cases
xamination  for  late  ventricular  potentials.  If  results  are
nconclusive,  an  MRI  may  be  performed.  Given  the  frequency
f  isolated  infundibular  systoles  in  the  general  population
nd  the  low  incidence  of  ARVD,  an  MRI  is  not  warranted  in
ach  patient  as  a  ﬁrst-line  investigation.
atecholaminergic polymorphic ventricular
achycardia
enetic  channelopathy  with  familial  transmission  is  char-
cterized  by  severe  polymorphic  ventricular  arrhythmias
nduced  by  adrenergic  stress  (physical  effort,  sport).  The
rrhythmias  occur  in  children  and  young  adults  without
nderlying  heart  disease  and  cause  convulsion,  syncope
nd/or  sudden  death.  The  differential  diagnosis  of  ARVD  may
e  based  on  the  clinical  signs.  The  MRI  ﬁndings  are  normal
nd  the  typical  stress  test  results  conﬁrm  the  diagnosis.
arcoidosis
ardiac  involvement  is  often  part  of  a  multi  organ  involve-
ent  of  this  disease  but  is  also,  in  some  rare  cases,  limited
o  the  single  cardiac  site.  The  most  common  sites  of  sarcoid
ranulomatous  inﬁltration  are  located  in  the  basal  interven-
ricular  septum,  and  the  LV  anteroseptal  wall.
Several  cases  of  isolated  RV  involvement  with  clinical
nd  imaging  ﬁndings  highly  suggestive  of  ARVD  have  been
escribed.  RV  involvement  in  sarcoidosis  can  occur  as  a
ilatation  and  dysfunction  of  the  RV,  with  focal  akinesia,
yskinesia  or  aneurysm  raising  the  question  of  the  differen-
ial  diagnosis  of  ARVD.
yocarditisases  of  myocarditis  mimicking  ARVD  have  been  reported.
hey  are  characterized  by  selective  involvement  of  the  right
entricle  causing  functional  and  structural  abnormalities
uch  as  microaneurysms.
ntricular dysplasia (ARVD) based on wall motion abnormalities and
subepicardium and midwall delayed contrast enhancement in the
w; b: delayed enhancement short axis, different slice.
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of families with arrhythmogenic right ventricular dyspla-60  
Moreover,  histological  evidence  of  myocarditis  has  often
een  evidenced  in  endomyocardial  biopsies  from  patients
ith  ARVD,  pointing  to  the  hypothesis  that  the  disease  may
ave  an  inﬂammatory  etiology.  Also,  some  viruses  (ade-
ovirus,  enterovirus,  coxsackievirus)  are  known  for  their
igher  cardiac  tropism  in  ARVD  patients.  The  role  of  these
iruses  in  the  pathophysiology  of  ARVD  is  not  yet  known,  and
articularly  whether  they  contribute  to  the  development  of
he  disease  or  whether  a  dysplasia-affected  myocardium  is
ore  prone  to  virus  infection.  Nevertheless,  viruses  should
e  considered  a  signiﬁcant  environmental  factor  with  prob-
bly  a  key  role  in  the  development  of  the  disease.
hl anomaly
hl  anomaly,  a  very  rare  congenital  heart  disease  (84  cases
ere  described  in  the  literature  up  to  1993),  was  ﬁrst
escribed  in  1952.  It  is  characterized  by  the  absence  of  right
entricular  free  wall  myocardium,  with  normal  interventric-
lar  septum  and  LV  wall.
Endocardium  and  pericardium  are  directly  apposed,  with
o  interposed  adipose  tissue,  which  makes  the  RV  look  like
‘parchment’’.  The  tricuspid  valve  has  a  normal  shape  and
inges  normally.
Clinical  signs  appear  in  childhood  with  both  genders
qually  affected,  and  without  any  signiﬁcant  family  history.
he  disease  progresses  rapidly,  and  is  often  fatal  in  the
bsence  of  cardiac  transplant.  Symptoms  include  dyspnea,
yanosis,  and  edema  in  lower  limbs  due  to  right  ventricu-
ar  failure.  The  etiology  is  unknown  but  may  be  related  to
poptosis.
The  MRI  images  depict  an  extremely  thin-walled  RV,  due
o  the  absence  of  myocardium,  associated  with  progressive
V  dilatation.  The  right  atrium  is  dilated  and  hypertrophied
ue  to  congestive  heart  failure.
onclusion
ardiac  MRI  is  frequently  performed  in  patients  with  sus-
ected  ARVD.  However,  the  number  of  diagnosed  cases  is
ow.  Despite  the  update  of  the  diagnostic  criteria  in  2010,
he  speciﬁcity  of  the  ARVD  diagnosis  remains  high,  but  its
ensitivity  has  remained  unchanged.  Diagnosis  is  still  chal-
enging  whatever  the  imaging  modality  used.  MRI  is  the  most
ighly  reproducible  and  speciﬁc  technique  for  assessing  the
orphology  and  segmental  wall  motion  of  the  right  ven-
ricle.  The  assessment  remains  highly  observer-dependent
nd  requires  a  deep  knowledge  of  MRI  images  of  normal
V  as  well  as  those  of  abnormalities  suggestive  of  ARVD.
ultidisciplinary  management  is  mandatory  for:
correctly  prescribing  cardiac  MRI;
handling  ﬁrst-degree  relatives  screening;
initiating  treatment  and  appropriate  clinical  follow-up.A.  Tavano  et  al.
ppendix A. Supplementary data
upplementary  data  associated  with  this  article  can
e  found,  in  the  online  version,  at  doi:10.1016/j.diii.
014.07.009.
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